Heart Failure POC & LOC Devices Market Research Report Information Information By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-based Systems), By End User (Hospitals & Clinics, Homecare, Specialty Centers, Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Technology

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL HEART FAILURE POC & LOC DEVICESMARKET, BY TEST TYPE

6.1. Overview

6.2. Proteomic Testing

6.3. Metabolomic Testing

6.4. Genomic Testing

7. GLOBAL HEART FAILURE POC & LOC DEVICESMARKET, BY TECHNOLOGY

7.1. Overview

7.2. Microfluidics

7.3. Array-based Systems

7.4. Others

8. GLOBAL HEART FAILURE POC & LOC DEVICESMARKET, BY END USER

8.1. Overview

8.2. Hospitals & Clinics

8.3. Homecare

8.4. Specialty Centers

8.5. Others

9. GLOBAL HEART FAILURE POC & LOC DEVICESMARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Heart Failure POC & LOC DevicesMarket

10.5. Competitive Benchmarking

10.6. Leading Players in terms of Number of Developments in the Global Heart Failure POC & LOC DevicesMarket

10.7. Key Developments and Growth Strategies

10.7.1. New ProductLaunch/Service Deployment

10.7.2. Merger &Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2020

10.8.2. Major Players R&D Expenditure, 2020

11. COMPANY PROFILES

11.1. Abbott (US)

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. F. Hoffmann-La Roche Ltd. (Switzerland)

11.3. Danaher (US)

11.4. Abaxis, Inc. (US)

11.5. Quidel Corporation (US)

11.6. Siemens Healthineers (Germany)

11.7. Jant Pharmacal Corporation (US)

11.8. Trinity Biotech (Ireland)

11.9. bioMérieux S.A (France)

11.10. Instrumentation Laboratory Company (US)

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SYNOPSIS, 2022–2030

TABLE 2 GLOBAL HEART FAILURE POC & LOC DEVICES MARKET ESTIMATES & FORECAST, 2022–2030 (USD MILLION)

TABLE 3 GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 4 GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 6 NORTH AMERICA: HEART FAILURE POC & LOC DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 8 NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 10 US: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 11 US HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 12 US: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 13 CANADA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 14 CANADA HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 15 CANADA: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 16 EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 17 EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 18 EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 19 EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 20 GERMANY: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 21 GERMANY: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 22 GERMANY: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 23 FRANCE: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 24 FRANCE: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 25 FRANCE: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 26 ITALY: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 27 ITALY: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 28 ITALY: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 29 SPAIN: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 30 SPAIN: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 31 SPAIN: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 32 UK: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 33 UK: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 34 UK: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 35 REST OF EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 36 REST OF EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 37 REST OF EUROPE: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 38 ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 39 ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 40 ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 41 ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 42 JAPAN: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 43 JAPAN: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 44 JAPAN: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 45 CHINA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 46 CHINA: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 47 CHINA: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 48 INDIA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 49 INDIA: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 50 INDIA: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 51 AUSTRALIA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 52 AUSTRALIA: HEART FAILURE POC & LOC DEVICES MARKET, TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 53 AUSTRALIA: HEART FAILURE POC & LOC DEVICES MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 54 SOUTH KOREA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 55 SOUTH KOREA: HEART FAILURE POC & LOC DEVICES MARKET, TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 56 SOUTH KOREA: HEART FAILURE POC & LOC DEVICES MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 57 REST OF ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 58 REST OF ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)

TABLE 59 REST OF ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 60 REST OF THE WORLD: HEART FAILURE POC & LOC DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 61 REST OF THE WORLD: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 62 REST OF THE WORLD: HEART FAILURE POC & LOC DEVICES MARKET, TECHNOLOGY 2022–2030 (USD MILLION)

TABLE 63 REST OF THE WORLD: HEART FAILURE POC & LOC DEVICES MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 64 MIDDLE EAST: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 65 MIDDLE EAST: HEART FAILURE POC & LOC DEVICES MARKET, TECHNOLOGY 2022–2030 (USD MILLION)

TABLE 66 MIDDLE EAST: HEART FAILURE POC & LOC DEVICES MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 67 AFRICA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 68 AFRICA: HEART FAILURE POC & LOC DEVICES MARKET, TECHNOLOGY 2022–2030 (USD MILLION)

TABLE 69 AFRICA: HEART FAILURE POC & LOC DEVICES MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 70 LATIN AMERICA: HEART FAILURE POC & LOC DEVICES MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 71 LATIN AMERICA: HEART FAILURE POC & LOC DEVICES MARKET, TECHNOLOGY 2022–2030 (USD MILLION)

TABLE 72 LATIN AMERICA: HEART FAILURE POC & LOC DEVICES MARKET, END USER, 2022–2030 (USD MILLION)

TABLE 73 MAJOR MANUFACTURERS IN THE GLOBAL HEART FAILURE POC & LOC DEVICES MARKET

TABLE 74 MOST ACTIVE PLAYER IN THE GLOBAL HEART FAILURE POC & LOC DEVICES MARKET

TABLE 75 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 76 PARTNERSHIP/AGREEMENT

TABLE 77 ACQUISITIONS

TABLE 78 EXPANSION

TABLE 79 ABBOTT: PRODUCTS/SERVICES OFFERED

TABLE 80 ABBOTT: KEY DEVELOPMENTS

TABLE 81 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED

TABLE 82 F. HOFFMANN-LA ROCHE LTD.: KEY DEVELOPMENTS

TABLE 83 DANAHER: PRODUCTS/SERVICES OFFERED

TABLE 84 DANAHER: KEY DEVELOPMENTS

TABLE 85 ABAXIS, INC.: PRODUCTS/SERVICES OFFERED

TABLE 86 ABAXIS, INC.: KEY DEVELOPMENTS

TABLE 87 QUIDEL CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 88 QUIDEL CORPORATION: KEY DEVELOPMENTS

TABLE 89 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED

TABLE 90 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS

TABLE 91 JANT PHARMACAL CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 92 JANT PHARMACAL CORPORATION: KEY DEVELOPMENTS

TABLE 93 TRINITY BIOTECH: PRODUCTS/SERVICES OFFERED

TABLE 94 TRINITY BIOTECH: KEY DEVELOPMENTS

TABLE 95 BIOMÉRIEUX S.A.: PRODUCTS/SERVICES OFFERED

TABLE 96 BIOMÉRIEUX S.A.: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HEART FAILURE POC & LOC DEVICESMARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HEART FAILURE POC & LOC DEVICESMARKET

FIGURE 4 GLOBAL HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY TEST TYPE, 2020 (%)

FIGURE 5 GLOBAL HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY TECHNOLOGY, 2020 (%)

FIGURE 6 GLOBAL HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY END USER, 2020 (%)

FIGURE 7 GLOBAL HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 EUROPE: HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 ASIA-PACIFIC: HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 REST OF THE WORLD: HEART FAILURE POC & LOC DEVICESMARKET SHARE, BY REGION, 2020 (%)

FIGURE 12 GLOBAL HEART FAILURE POC & LOC DEVICESMARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 13 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 14 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL HEART FAILURE POC & LOC DEVICES MARKET

FIGURE 15 GLOBAL HEART FAILURE POC & LOC DEVICES MARKET: COMPETITIVE LANDSCAPE

FIGURE 16 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 ABBOTT: SWOT ANALYSIS

FIGURE 18 F. HOFFMANN-LA ROCHE LTD.:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 F. HOFFMANN-LA ROCHE LTD.:SWOT ANALYSIS

FIGURE 20 DANAHER:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 DANAHER.:SWOT ANALYSIS

FIGURE 22 ABAXIS, INC.:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 ABAXIS, INC.:SWOT ANALYSIS

FIGURE 24 QUIDEL CORPORATION:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 QUIDEL CORPORATION:SWOT ANALYSIS

FIGURE 26 SIEMENS HEALTHINEERS:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 SIEMENS HEALTHINEERS:SWOT ANALYSIS

FIGURE 28 JANT PHARMACAL CORPORATION:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 JANT PHARMACAL CORPORATION:SWOT ANALYSIS

FIGURE 30 TRINITY BIOTECH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 TRINITY BIOTECH: SWOT ANALYSIS

FIGURE 32 BIOMÉRIEUX S.A.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 BIOMÉRIEUX S.A.: SWOT ANALYSIS

FIGURE 34 INSTRUMENTATION LABORATORY COMPANY (US):FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 INSTRUMENTATION LABORATORY COMPANY (US):SWOT ANALYSIS